Victorian researchers have characterised a protein, VDAC2, as a key component of the apoptosis process used by anti-cancer agents such as venetoclax. Walter and Eliza Hall Institute scientists have identified VDAC2 (voltage-dependent anion channel 2) as important for the function of the protein BAX to drive apoptotic cell death. BAX is one of two essential ...
WEHI apoptosis research may help overcome chemo resistance
4 Dec 2018